| MEXPRESS: visualizing expression, DNA methylation and clinical TCGA data A Koch, T De Meyer, J Jeschke, W Van Criekinge BMC genomics 16, 1-6, 2015 | 311 | 2015 |
| MEXPRESS update 2019 A Koch, J Jeschke, W Van Criekinge, M van Engeland, T De Meyer Nucleic acids research 47 (W1), W561-W565, 2019 | 188 | 2019 |
| Genomic and epigenomic integration identifies a prognostic signature in colon cancer JM Yi, M Dhir, L Van Neste, SR Downing, J Jeschke, SC Glöckner, ... Clinical Cancer Research 17 (6), 1535-1545, 2011 | 172 | 2011 |
| DNA methylation–based immune response signature improves patient diagnosis in multiple cancers J Jeschke, M Bizet, C Desmedt, E Calonne, S Dedeurwaerder, S Garaud, ... The Journal of clinical investigation 127 (8), 3090-3102, 2017 | 125 | 2017 |
| Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells C Siebenkäs, KB Chiappinelli, AA Guzzetta, A Sharma, J Jeschke, ... PLoS One 12 (6), e0179501, 2017 | 93 | 2017 |
| Frequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclines J Jeschke, HM O'Hagan, W Zhang, R Vatapalli, MF Calmon, L Danilova, ... Clinical Cancer Research 19 (12), 3201-3211, 2013 | 91 | 2013 |
| Epigenetic silencing of neurofilament genes promotes an aggressive phenotype in breast cancer MF Calmon, J Jeschke, W Zhang, M Dhir, C Siebenkäs, A Herrera, ... Epigenetics 10 (7), 622-632, 2015 | 78 | 2015 |
| Biomarkers for detection and prognosis of breast cancer identified by a functional hypermethylome screen J Jeschke, L Van Neste, SC Glöckner, M Dhir, MF Calmon, V Deregowski, ... Epigenetics 7 (7), 701-709, 2012 | 75 | 2012 |
| Portraits of TET-mediated DNA hydroxymethylation in cancer J Jeschke, E Collignon, F Fuks Current opinion in genetics & development 36, 16-26, 2016 | 68 | 2016 |
| Sessile serrated adenomas and classical adenomas: an epigenetic perspective on premalignant neoplastic lesions of the gastrointestinal tract M Dhir, S Yachida, LV Neste, SC Glöckner, J Jeschke, EP Pappou, ... International journal of cancer 129 (8), 1889-1898, 2011 | 66 | 2011 |
| Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome IAG Deckers, LJ Schouten, L Van Neste, IJH Van Vlodrop, ... Clinical Cancer Research 21 (15), 3492-3500, 2015 | 63 | 2015 |
| A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients IJH Van Vlodrop, SC Joosten, T De Meyer, KM Smits, L Van Neste, ... Clinical cancer research 23 (8), 2006-2018, 2017 | 62 | 2017 |
| Genome-wide hydroxymethylcytosine pattern changes in response to oxidative stress B Delatte, J Jeschke, M Defrance, M Bachman, C Creppe, E Calonne, ... Scientific reports 5 (1), 12714, 2015 | 60 | 2015 |
| CpG Island Methylator Phenotype–Positive Tumors in the Absence of MLH1 Methylation Constitute a Distinct Subset of Duodenal Adenocarcinomas and Are … T Fu, EP Pappou, AA Guzzetta, J Jeschke, R Kwak, P Dave, CM Hooker, ... Clinical cancer research 18 (17), 4743-4752, 2012 | 54 | 2012 |
| Methylation of the claudin 1 promoter is associated with loss of expression in estrogen receptor positive breast cancer F Di Cello, L Cope, H Li, J Jeschke, W Wang, SB Baylin, CA Zahnow PloS one 8 (7), e68630, 2013 | 50 | 2013 |
| Downregulation of the FTO m6A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors J Jeschke, E Collignon, C Al Wardi, M Krayem, M Bizet, Y Jia, S Garaud, ... Nature cancer 2 (6), 611-628, 2021 | 37 | 2021 |
| DNA methylome profiling beyond promoters–taking an epigenetic snapshot of the breast tumor microenvironment J Jeschke, E Collignon, F Fuks The FEBS journal 282 (9), 1801-1814, 2015 | 35 | 2015 |
| KRAS G> A mutation favors poor tumor differentiation but may not be associated with prognosis in patients with curatively resected duodenal adenocarcinoma T Fu, AA Guzzetta, J Jeschke, R Vatapalli, P Dave, CM Hooker, R Morgan, ... International journal of cancer 132 (11), 2502-2509, 2013 | 17 | 2013 |
| CpG island methylator phenotype and its association with malignancy in sporadic duodenal adenomas L Sun, AA Guzzetta, T Fu, J Chen, J Jeschke, R Kwak, R Vatapalli, ... Epigenetics 9 (5), 738-746, 2014 | 10 | 2014 |
| Why novel mRNA modifications are so challenging and what we can do about it A Penning, J Jeschke, F Fuks Nature Reviews Molecular Cell Biology 23 (6), 385-386, 2022 | 6 | 2022 |
James HermanUniversity of PittsburghEmail verificata su upmc.edu
